---
title: "Mr Monsur Yazdani Khan — Ownership Dossier"
canonical: https://whiteintel.dev/entity/69cf60e6-a323-41dd-bd02-39735f7fe0c7
json: https://whiteintel.dev/api/public/dossier/69cf60e6-a323-41dd-bd02-39735f7fe0c7
identifier: psc:qYoxaz6LvA--ubX95umh2Z4xBJY
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Mr Monsur Yazdani Khan

**Type:** Person  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `psc:qYoxaz6LvA--ubX95umh2Z4xBJY`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/69cf60e6-a323-41dd-bd02-39735f7fe0c7  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/69cf60e6-a323-41dd-bd02-39735f7fe0c7  

## Ownership & control

### Holdings / subsidiaries

- **NASILA PHARMA LIMITED** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/ba25fbfe-b607-5ebb-99bf-82c98149f78f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Mr Monsur Yazdani Khan**. Human view: https://whiteintel.dev/entity/69cf60e6-a323-41dd-bd02-39735f7fe0c7 · Structured JSON: https://whiteintel.dev/api/public/dossier/69cf60e6-a323-41dd-bd02-39735f7fe0c7._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._